Global innovations and challenges in regenerative medicine

Summary: Advances global regulatory and policy discourse on regenerative medicine by providing a first-of-its-kind analysis of governance frameworks in low- and middle-income countries, highlighting diverse approaches and key challenges to support more coordinated and equitable global oversight.

Impact: Enhances understanding of regenerative medicine governance by illuminating policy landscapes in underexamined regions, thereby promoting more globally coherent and inclusive regulatory strategies

Summary: The report provides the first comprehensive mapping of mid-to late-stage regenerative medicine clinical trials and product pipelines in low- and middle- income countries in Africa and Asia. The report offers critical insights that support the inclusion of under examined regions in global regulatory and commercialization frameworks for regenerative medicine.

Impact: Strengthens global understanding of regenerative medicine by highlighting the clinical research and innovation landscape in under-examined low- and middle-income countries, thereby informing more inclusive and interoperable regulatory and policy frameworks.

Summary: The study makes a novel contribution to the literature by providing the first analysis of patients’ experiences and perceptions of an emerging cell-based therapy within an evolving regulatory landscape.

Impact: Provides critical insights to inform policy development, promote scientific rigor, and ensure ethical oversight of autologous cell-based therapies and other emerging cell-based therapies.